SESANA MARIA SILVIA

Ruolo: 
tecnico - amministrativo
Telefono: 
0264488228
Stanza: 
U28, Piano: P02, Stanza: 2009
Via Follerau, SN - 20854 VEDANO AL LAMBRO

Pubblicazioni

  • Gregori, M., Taylor, M., Salvati, E., Re, F., Mancini, S., Balducci, C., et al. (2017). Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide. NANOMEDICINE, 13(2), 723-732. Dettaglio
  • Zoia, C., Conti, E., Cereda, D., Rodriguez-Menendez, V., Andreoni, S., Gregori, M., et al. (2016). THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS. JOURNAL OF ALZHEIMER'S DISEASE. Dettaglio
  • Gregori, M., Orlando, A., Re, F., Sesana, S., Nardo, L., Salerno, D., et al. (2016). Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes. JOURNAL OF PHARMACEUTICAL SCIENCES, 105(1), 276-283. Dettaglio
  • Zoia, C., Conti, E., Ulisse, A., Rodriguez-Menendez, V., Gregori, M., Sesana, M.S., et al. (2015). Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease. In abstract book. Dettaglio
  • Gregori, M., Bertani, D., Cazzaniga, E., Orlando, A., Mauri, M., Bianchi, A., et al. (2015). Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro. MACROMOLECULAR BIOSCIENCE, 15(12), 1687-1697. Dettaglio